We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Sony
SONY
$138B
| $1.38M | ﹤0.01% |
83,530
+1,300
| +2% | +$22.7K |
|
|
CVGW
2027
DELISTED
Calavo Growers
CVGW
| $1.37M | ﹤0.01% |
54,483
+26
| +0% | +$845 |
|
2028
Pliant Therapeutics
PLRX
$65M
| $1.37M | ﹤0.01% |
79,097
+255
| +0.3% | +$4.42K |
|
2029
Maravai LifeSciences
MRVI
$919M
| $1.37M | ﹤0.01% |
136,927
-22,310
| -14% | -$245K |
|
2030
OceanFirst Financial
OCFC
$1.91B
| $1.37M | ﹤0.01% |
94,511
-181
| -0.2% | -$3.05K |
|
2031
Xperi
XPER
$348M
| $1.37M | ﹤0.01% |
138,607
+1,805
| +1% | +$21.3K |
|
|
SHOE
2032
Shoe Station Group
SHOE
$428M
| $1.37M | ﹤0.01% |
56,837
+2,086
| +4% | +$49.5K |
|
2033
Grupo Aeroportuario del Sureste
ASR
$8.3B
| $1.37M | ﹤0.01% |
5,558
+22
| +0.4% | +$5.95K |
|
2034
AvePoint
AVPT
$2.71B
| $1.36M | ﹤0.01% |
202,840
+1,561
| +0.8% | +$9.84K |
|
|
LGF.B
2035
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $1.36M | ﹤0.01% |
173,085
+3,192
| +2% | +$24K |
|
2036
The RMR Group
RMR
$332M
| $1.36M | ﹤0.01% |
55,325
-26,914
| -33% | -$649K |
|
2037
Nicolet Bankshares
NIC
$3.62B
| $1.36M | ﹤0.01% |
19,428
+45
| +0.2% | +$3.39K |
|
2038
Arvinas
ARVN
$572M
| $1.36M | ﹤0.01% |
69,000
+278
| +0.4% | +$6.82K |
|
2039
Old Second Bancorp
OSBC
$1.29B
| $1.36M | ﹤0.01% |
99,568
-22,649
| -19% | -$331K |
|
2040
MiMedx Group
MDXG
$633M
| $1.35M | ﹤0.01% |
185,803
+6,294
| +4% | +$46.9K |
|
2041
IMAX
IMAX
$2.66B
| $1.35M | ﹤0.01% |
70,025
+1,175
| +2% | +$21.7K |
|
|
RVNC
2042
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.35M | ﹤0.01% |
117,779
+1,753
| +2% | +$33.7K |
|
2043
Gates Industrial Corporation Ltd.
GTES
$7.15B
| $1.35M | ﹤0.01% |
116,171
-8,505
| -7% | -$106K |
|
2044
ACM Research
ACMR
$5.79B
| $1.35M | ﹤0.01% |
74,381
-155
| -0.2% | -$2.31K |
|
2045
TETRA Technologies
TTI
$1.26B
| $1.35M | ﹤0.01% |
210,962
-16,257
| -7% | -$83.7K |
|
2046
Central Garden & Pet Co
CENT
$2.8B
| $1.34M | ﹤0.01% |
38,071
-270
| -0.7% | -$9.27K |
|
2047
Enact Holdings
ACT
$6.73B
| $1.34M | ﹤0.01% |
49,347
+1,846
| +4% | +$51.3K |
|
|
ETWO
2048
DELISTED
E2open Parent Holdings
ETWO
| $1.34M | ﹤0.01% |
295,654
-30,548
| -9% | -$151K |
|
|
UMH
2049
UMH Properties
UMH
$1.36B
| $1.33M | ﹤0.01% |
95,157
-18,514
| -16% | -$285K |
|
2050
Huazhu Hotels Group
HTHT
$13B
| $1.33M | ﹤0.01% |
33,743
+17
| +0.1% | +$717 |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.